Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 110

Sort by

Sort Order Select

Journal Articles

Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia

Shanshan Suo, Dandan Zhao, Fenglin Li, Yi Zhang, Sonia Rodriguez-Rodriguez, Le Xuan Truong Nguyen, Lucy Ghoda, Nadia Carlesso, Guido Marcucci, Bin Zhang, Jie Jin

Blood (2024) 144 (12): 1343–1347.

https://doi.org/10.1182/blood.2023023400

Published: 2024

Includes: Supplemental data

Journal Articles

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD

Ying Wang, Shan He, Gennaro Calendo, Tien Bui, Yuanyuan Tian, Che Young Lee, Yan Zhou, Xin Zhao, Ciril Abraham, Wenbin Mo, Mimi Chen, Ruqayyah Sanders-Braggs, Jozef Madzo, Jean-Pierre Issa, Elizabeth O. Hexner, David L. Wiest, Ran Reshef, Hai-Hui Xue, Yi Zhang

Blood (2024) 143 (2): 166–177.

https://doi.org/10.1182/blood.2023021126

Published: 2024

Includes: Supplemental data

Journal Articles

Identification of Characteristics and Prognostic Impact of FUS-ERG and AML1-MTG16 Fusion Genes in Adult AML Patients

Ziyue Zhou, Yile Zhou, Caihong Sun, Yiyi Yao, Liping Mao, Yi Zhang, Qing Hong, Nanfang Zhuo, Peifeng Pan, Hongyan Tong, Jie Jin, Huafeng Wang

Blood (2023) 142 (Supplement 1): 1485.

https://doi.org/10.1182/blood-2023-185970

Published: 2023

Journal Articles

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

Blood (2023) 142 (Supplement 1): 2106.

https://doi.org/10.1182/blood-2023-180387

Published: 2023

Journal Articles

STI-8591, a Novel Tyrosine Kinase Inhibitor, Shows Excellent Antileukemic Activity in FLT3 -Mutated (mut) Acute Myeloid Leukemia (AML)

Yi Zhang, Wenwen Wei, Bin Zhang, Jie Sun, Dandan Zhao, Fang Chen, Yongfang Xu, Yu Qian, Yanchun Zhao, Yutong Zhou, Wanhong Xu, Xiaoying Zhang, Long Mao, Guido Marcucci, Xiao Xu, Jie Jin

Blood (2023) 142 (Supplement 1): 5010.

https://doi.org/10.1182/blood-2023-174745

Published: 2023

Journal Articles

CD19/BCMA Dual-Targeting Fastcar-T GC012F for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: An Update

Xinfeng Chen, Yu Ping, Ling Li, Lei Zhang, Xudong Zhang, Jianmin Huang, Jia Liu, Gui Li, Huan Shi, Jiaping He, Yi Liang, Lihong Weng, Wenjie Yin, Lianjun Shen, Wei William Cao, Wenling Li, Mingzhi Zhang, Yi Zhang

Blood (2023) 142 (Supplement 1): 6847.

https://doi.org/10.1182/blood-2023-185476

Published: 2023

Journal Articles

Dysregulation of Immune Regulators in AML Bone Marrow Promotes Dysfunction of CD8 + T Cells

Yongping Zhang, Yuanyuan Tian, Lijun Meng, Qi Ji, Yijun Wu, Chenwei Yang, Li Gao, Yixin Hu, Yanhua Yao, Peifang Xiao, Jun Lu, Hailong He, Yi Zhang, Shaoyan Hu

Blood (2023) 142 (Supplement 1): 5616.

https://doi.org/10.1182/blood-2023-187900

Published: 2023

Journal Articles

IL1RAP-Specific T Cell Engager (TCE) Antibody Efficiently Depletes Acute Myeloid Leukemia (AML) Leukemic Stem Cells (LSCs)

Blood (2023) 142 (Supplement 1): 586.

https://doi.org/10.1182/blood-2023-185405

Published: 2023

Journal Articles

Acquired microRNA-142 Deficit Drives Escape Mechanisms of Anti-Leukemic Surveillance during Blast Crisis Transformation of Chronic Myeloid Leukemia (CML)

Blood (2023) 142 (Supplement 1): 3152.

https://doi.org/10.1182/blood-2023-182587

Published: 2023

Journal Articles

Phase Separation of PML/RARα Microspeckles Governs Transcriptional Dysregulation through Genomic Rewiring of BRD4 in Acute Promyelocytic Leukemia

Yi Zhang, Kankan Wang, Jiacheng Lou, Yabin Liu, Peng Jin, Yun Tan, Huan Song, Wen Jin, Fangyi Dong, Shishuang Wu, Hai Fang

Blood (2023) 142 (Supplement 1): 1367.

https://doi.org/10.1182/blood-2023-180510

Published: 2023

Journal Articles

Localization of DC-SIGN Expressing Cells in Follicular Lymphoma

Dingani Nkosi, Philip J Rock, Rachel C Gargan, Richard Burack, Yi Zhang

Blood (2023) 142 (Supplement 1): 6122.

https://doi.org/10.1182/blood-2023-186214

Published: 2023

Journal Articles

Dual Functions of Mitochondrial Calcium Uniporter in T Cell Alloimmunity

Ying WANG, Alicia Huaze Li, Ruqayyah sanders-Braggs, Yan Zhou, Mimi Chen, Tien Bui, Hongfa Zhu, Jonathan Soboloff, John Elrod, Elizabeth O Hexner, Yi Zhang

Blood (2023) 142 (Supplement 1): 4787.

https://doi.org/10.1182/blood-2023-190563

Published: 2023

Journal Articles

Synergistic Activity of Adefovir Dipivoxil and Venetoclax to Target the Bioenergetic Metabolism of Acute Myeloid Leukemia

Xubo Gong, Yi Zhang, Ying-Chieh Chen, Dandan Zhao, Yongfang Xu, Xin He, Fang Chen, Lei Zhang, Lianjun Zhang, Katrina Estrella, Melissa Valerio, Lucy Y. Ghoda, Le Xuan Truong Nguyen, Ya-Huei Kuo, Weiwei Liu, Zhihua Tao, Guido Marcucci, Bin Zhang

Blood (2023) 142 (Supplement 1): 4161.

https://doi.org/10.1182/blood-2023-187183

Published: 2023

Journal Articles

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 6001.

https://doi.org/10.1182/blood-2023-186048

Published: 2023

Journal Articles

Efficacy, Safety, and Survival Findings after Long-Term Follow-up from ZGJAK002, a Phase 2 Study Comparing Jaktinib 100 Mg Twice Daily with 200 Mg Once Daily for Myelofibrosis (MF)

Blood (2023) 142 (Supplement 1): 1814.

https://doi.org/10.1182/blood-2023-179043

Published: 2023

Journal Articles

A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis

Blood (2023) 141 (9): 1070–1086.

https://doi.org/10.1182/blood.2022017262

Published: 2023

Includes: Supplemental data

Journal Articles

Venetoclax Plus "2 + 5" Modified Intensive Chemotherapy with Daunorubicin and Cytarabine in Fit Elderly Patients with Untreated De Novo Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Huafeng Wang, Yiyi Yao, Liping Mao, Yinjun Lou, Yanling Ren, Xingnong Ye, Min Yang, Liya Ma, Yi Zhang, Yile Zhou, Xin Huang, Yungui Wang, Huan Xu, Hongyan Tong, Hong-hu Zhu, Jie Jin

Blood (2022) 140 (Supplement 1): 3350–3351.

https://doi.org/10.1182/blood-2022-165738

Published: 2022

Journal Articles

Patient-Reported Outcomes from a Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria

Chris Hartford, Bradley Dain, Steven Sherman, Yi Zhang, Rodrigo Pavani, Lisa Aurand, Diana Rofail, Richard Kelly

Blood (2022) 140 (Supplement 1): 10849–10850.

https://doi.org/10.1182/blood-2022-163510

Published: 2022

Journal Articles

SC-gtCAR19, a Non-Viral Genome Targeting Anti-CD19 CAR-T Candidate in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: Updated Results from Long-Term Follow-up

Hui Wang, Ying Gao, Ding Zhang, Yan Zheng, Xingxing Hu, Qiuying Gao, Ben Niu, Limin Hou, Ling Wang, Weihua Zhang, Yi Zhang, Xingli Ru, Le Li, Zuohan Peng, Yi Wang

Blood (2022) 140 (Supplement 1): 4623–4624.

https://doi.org/10.1182/blood-2022-159871

Published: 2022

Journal Articles

Homoharringtonine Synergizes Strongly with Venetoclax Against the Early T-Cell Progenitor Acute Lymphoblastic Leukemia：from Bench to Bed

Blood (2022) 140 (Supplement 1): 2263–2264.

https://doi.org/10.1182/blood-2022-170604

Published: 2022

NARROW

Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD

Identification of Characteristics and Prognostic Impact of FUS-ERG and AML1-MTG16 Fusion Genes in Adult AML Patients

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

STI-8591, a Novel Tyrosine Kinase Inhibitor, Shows Excellent Antileukemic Activity in FLT3 -Mutated (mut) Acute Myeloid Leukemia (AML)

CD19/BCMA Dual-Targeting Fastcar-T GC012F for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma: An Update

Dysregulation of Immune Regulators in AML Bone Marrow Promotes Dysfunction of CD8 + T Cells

IL1RAP-Specific T Cell Engager (TCE) Antibody Efficiently Depletes Acute Myeloid Leukemia (AML) Leukemic Stem Cells (LSCs)

Acquired microRNA-142 Deficit Drives Escape Mechanisms of Anti-Leukemic Surveillance during Blast Crisis Transformation of Chronic Myeloid Leukemia (CML)

Phase Separation of PML/RARα Microspeckles Governs Transcriptional Dysregulation through Genomic Rewiring of BRD4 in Acute Promyelocytic Leukemia

Localization of DC-SIGN Expressing Cells in Follicular Lymphoma

Dual Functions of Mitochondrial Calcium Uniporter in T Cell Alloimmunity

Synergistic Activity of Adefovir Dipivoxil and Venetoclax to Target the Bioenergetic Metabolism of Acute Myeloid Leukemia

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

Efficacy, Safety, and Survival Findings after Long-Term Follow-up from ZGJAK002, a Phase 2 Study Comparing Jaktinib 100 Mg Twice Daily with 200 Mg Once Daily for Myelofibrosis (MF)

A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis

Venetoclax Plus "2 + 5" Modified Intensive Chemotherapy with Daunorubicin and Cytarabine in Fit Elderly Patients with Untreated De Novo Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Patient-Reported Outcomes from a Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria

SC-gtCAR19, a Non-Viral Genome Targeting Anti-CD19 CAR-T Candidate in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: Updated Results from Long-Term Follow-up

Homoharringtonine Synergizes Strongly with Venetoclax Against the Early T-Cell Progenitor Acute Lymphoblastic Leukemia：from Bench to Bed

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only